I’m not sure there’s anything more Italian than this.

Police arrested a doctor after a fight with another physician turned physical at St. Elizabeth in Boardman.

This randomized clinical trial investigates the risk of kidney outcomes among patients with progressive IgA nephropathy receiving mycophenolate mofetil with supportive care vs supportive care alone.

Beginning in July 2023, this fellowship will help train nephrologists to rapidly expand knowledge and further research towards more effective treatments.

Lupus nephritis is a severe, organ-threatening manifestation of systemic lupus erythematosus. The current standard of care in the treatment of lupus nephritis is limited to broad-spectrum immunosup...

Educator in nephrology to be honored at NKF’s 2021 Spring Clinical Meetings Nov. 18, 2020, New York, NY —Each year the National Kidney Foundation (NKF) considers the work of hundreds of specialists

Immune checkpoint inhibitors (ICIs) are increasingly used to treat cancers. Kidney immune-related adverse events (IRAEs) are now well recognized, with the incidence of IRAEs ranging from 2% to 5%....

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a small-vessel vasculitis with a predilection for the kidney.1 Morbidity and mortality among patients with AAV are largely...

Sodium/glucose cotransporter 2 (SGLT2) inhibitors have demonstrated a class effect in improving serum magnesium levels in patients with diabetes. Additionally, recent reports have shown their...

Amyloid A amyloidosis is thought to be the second most common form of systemic amyloidosis behind amyloidosis secondary to monoclonal Ig. It is the result of deposition of insoluble fibrils in the...

A cyclical corticosteroid-cyclophosphamide regimen is recommended for patients with primary membranous nephropathy at high risk of progression. We hypothesized that sequential therapy with tacrolimus...

The FDA clearance was based on data from the PRAECIS study.

45,000 workers, including doctors, nurses, and "unsung heroes," are eligible for a cash bonus and extra time off, Northwell Health said on Monday.

CA: A Cancer Journal for Clinicians is ACS' flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.

The authors review the pathophysiology, revised diagnostic definitions, and management of acute kidney injury, a common condition in patients with cirrhosis.

Scientific Reports - The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis

Thrombotic microangiopathy (TMA), a pathological lesion observed in a wide spectrum of diseases, is triggered by endothelial injury and/or dysfunction. Although TMA lesions are often accompanied by...

Several studies have suggested that patients with kidney failure may benefit from high-dose hemodiafiltration as compared with standard hemodialysis. However, given the limitations of the various p...

Monoclonal gammopathy of renal significance is a B-cell or plasma-cell clonal disorder that does not meet the criteria for cancer but produces a monoclonal immunoglobulin that leads to kidney injur...

Nature Reviews Nephrology - Multiple pathophysiological disturbances contribute to the onset and progression of diabetic kidney disease (DKD). This Review describes these pathogenic processes and...

ity in its clinical presentation and prognosis, requiring an individualized treatment approach. Goal-directed supportive care remains the bedrock of therapy for all patients, regardless of risk of...

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of disorders characterized by inflammation and destruction of small- and medium-sized blood vessels and the presence...

This randomized clinical trial assesses the efficacy and safety of tacrolimus vs intravenous cyclophosphamide as an initial treatment for lupus nephritis in China.

A 20-year-old woman with refractory SLE with active lupus nephritis (WHO class IIIA), nephrotic syndrome, pericarditis, pleurisy, rash, arthritis, and a history of Libman–Sacks endocarditis ...

The FDA granted breakthrough therapy designation to the SGLT2 inhibitor dapagliflozin for adults with chronic kidney disease with and without type 2 diabetes, according to an industry press release....

Abstract. The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guidelines for glomerulonephritis shed light on the complex world of

AbstractAims. Randomized controlled trials have demonstrated the efficacy of mineralocorticoid receptor (MR) antagonism in delaying chronic kidney disease

Intravenous iodinated contrast media are commonly used with CT to evaluate disease and to determine treatment response. The risk of acute kidney injury (AKI) developing in patients with reduced...

Nature Reviews Nephrology - Sepsis-associated acute kidney injury (SA-AKI) is linked with poor outcomes in critically ill patients. This Consensus Statement from the Acute Disease Quality...